Abstract Alzheimer's disease (AD), also called senile dementia, is the most common
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …

Alzheimer's disease is a common neurological disorder, which has become one of the major
factors affecting human health due to its serious impact on individuals, families and society …

Abstract Alzheimer's disease (AD), a neurodegenerative condition, is defined by
neurofibrillary tangles, amyloid plaques, and gradual cognitive decline. Regardless of the …

Neurodegenerative disorders are characterised by progressive neuron loss in specific brain
areas. The most common are Alzheimer's disease and Parkinson's disease; in both cases …

The steroidogenic acute regulatory (StAR) protein principally mediates steroid hormone
biosynthesis by governing the transport of intramitochondrial cholesterol. Neurosteroids …

Alzheimer's disease (AD) and Alzheimer's related dementias (ADRD) are growing public
health concerns in aged populations of all ethnic and racial groups. AD and ADRD are …

Amyloid beta peptide is an important biomarker in Alzheimer's disease, with the
amyloidogenic hypothesis as one of the central hypotheses trying to explain this type of …

Abstract β‐Amyloid (Aβ) is a specific pathological hallmark of Alzheimer's disease (AD).
Because of its neurotoxicity, AD patients exhibit multiple brain dysfunctions. Disease …

Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) are late-onset,
age-related progressive neurodegenerative disorders, characterized by memory loss and …

It has been suggested that functional traits of the adult brain—all of which are established
early in life—may affect the brain's susceptibility to Alzheimer's disease (AD). Results of our …